ARIZONA CLINICAL TRIALS

NAFLD (Non-Alcoholic Fatty Liver Disease) or Fatty Liver, is a condition where the liver becomes infiltrated with fat. The fat is called steatosis; however, when flammation or scarring occurs, it is called steatohepatitis or NASH.

NASH means there is a presence of inflammation and scarring in the liver due to fatty infiltration or steatosis. This can progress to fibrosis, cirrhosis, liver failure and liver cancer. Up to 20% of the US population has fatty liver, and perhaps as many as 5% have NASH.

Cirrhosis is a condition where the liver becomes heavily scarred (or fibrotic); this can occur as a result of alcohol, viral hepatitis, fatty liver disease, or any other type of chronic liver disease.

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. There are many types of human coronaviruses, including some that commonly cause mild upper-respiratory tract illnesses.

COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans.